Active Ingredients (In Each Tablet)
Chlorpheniramine maleate 4 mg
Pseudoephedrine HCl 60 mg
The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Sudogest (NDC 0904-5351). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Chlorpheniramine maleate 4 mg
Pseudoephedrine HCl 60 mg
Antihistamine
Nasal decongestant
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
colloidal silicon dioxide, croscarmellose sodium, lactose anhydrous, magnesium stearate, microcrystalline cellulose, stearic acid
(800) 616-2471
MAJOR®
NDC 0904-5351-24
Maximum Strength
SudoGest Sinus & Allergy
Chlorpheniramine maleate 4 mg
Pseudoephedrine HCl 60 mg
4 mg/ 60 mg
Antihistamine/Nasal Decongestant
Runny Nose & Sneezing,
Itchy, Watery Eyes,
Sinus Congestion & Pressure
24 Tablets
50844 REV0619K11108
Distributed by
MAJOR® PHARMACEUTICALS
17177 N Laurel Park Drive, Suite 233
Livonia, MI 48152
Rev. 10/19 M-17
Re-order No. 235631
TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING
* Please review the disclaimer below.